Diese Studie enthält eine ausreichend große Teilnehmerzahl. Sie können sich hierfür nicht mehr an- oder abmelden.


Ort der Studie

Clinical trial of a new compound that has been developed for the treatment of bowel diseases


The research physician about this research

In this trial, the new compound will be administered once, directly into the vein. The period of stay in our clinic is followed by short visits for a number of months. The purpose of this trial is to investigate how quickly and to what extent the newly developed compound is absorbed, broken down, and eliminated by the body. This is compared to a similar compound that is already available on the market. 

Für Deutschland: Bitte beachten Sie: Die Arzneimittelstudien finden im niederländischen Groningen statt. Sie müssen Englisch oder Niederländisch sprechen, verstehen und lesen können, um an einer Studie teilnehmen zu können. 


Important information about this study

  • You will receive an interim payment (33% + travel costs) after the 4th short visit
  • Relatively few moments of research. Plenty of free time to relax, study or work remotely
  • Smokers and non-smokers are allowed to participate in this study


Group 24 9 Tage Aufenthalt
18 Mai 2023 bis einschl. 26 Mai 2023
kurzer Besuch
28 Mai 2023
2 Jun 2023
16 Jun 2023
30 Jun 2023
21 Jul 2023
11 Aug 2023
1 Sep 2023
22 Sep 2023
€ 4.116
Group 25 9 Tage Aufenthalt
29 Mai 2023 bis einschl. 6 Jun 2023
kurzer Besuch
8 Jun 2023
13 Jun 2023
27 Jun 2023
11 Jul 2023
1 Aug 2023
22 Aug 2023
12 Sep 2023
3 Okt 2023
€ 4.116
Groep 26 9 Tage Aufenthalt
6 Jun 2023 bis einschl. 14 Jun 2023
kurzer Besuch
16 Jun 2023
21 Jun 2023
5 Jul 2023
19 Jul 2023
9 Aug 2023
30 Aug 2023
20 Sep 2023
11 Okt 2023
€ 4.116
Group 27 9 Tage Aufenthalt
14 Jun 2023 bis einschl. 22 Jun 2023
kurzer Besuch
24 Jun 2023
29 Jun 2023
13 Jul 2023
27 Jul 2023
17 Aug 2023
7 Sep 2023
28 Sep 2023
19 Okt 2023
€ 4.116


Who can participate?

  • You are a healthy male or female
  • You are between 18 and 65 years old
  • Your Body Mass Index (BMI) is between 18.5 and 30.0 kg/m2.
  • Both non-smokers and smokers are allowed to participate in this clinical trial. However, smoking is not allowed during your stay in the research facility.


  • You cannot participate in the trial if you have participated in another clinical trial in the 30 days prior to the first administration in this clinical trial (counting from the last administration). This might be longer for certain trials, please contact us for more information.
  • To determine if you are suitable to participate in this trial, you will undergo a medical screening. Depending on availability, this can be performed in Groningen or in Utrecht.


As a female you can only participate if you are not pregnant, not breastfeeding, and meet one of the following conditions:

  • You are using hormonal contraception (for example the contraceptive pill or intra-uterine device containing hormones);
  • You are using a copper intra-uterine device;
  • You have passed the menopause (no period for at least 12 months);
  • You have been sterilized or your male partner has been sterilized;
  • You abstain from (hetero)sexual intercourse (you are not sexually active) according to your lifestyle.


As a male you can only participate if you meet one of the following conditions:

  • You are using a condom in combination with a contraception method used by your female partner;
  • You have been sterilized or your female partner is sterilized or has passed the menopause;
  • You abstain from (hetero)sexual intercourse (you are not sexually active) according to your lifestyle.



  • You will receive a gross compensation of € 4116 for participation in one of the groups.
  • Travel expenses will be reimbursed based on the distance traveled (€ 0,19 net per kilometer) with a minimum of € 12,- and a maximum of € 160,- (840 kilometers) per round trip, regardless of the mode of transportation.


Period of stay and research

The trial consists of 1 period during which you will stay in the research facility in Groningen for 9 days (8 nights), followed by 8 short visits including the follow-up.

PLEASE NOTE: You must be available for all dates to be able to participate in this study. 



© 2023 Link2Trials